Atlas FDA

Exogen Ultrasound Bone Healing System

FDA premarket approval P900009/S044 · decided 2019-12-20

Approval details

PMA number
P900009
Supplement
S044
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Exogen Ultrasound Bone Healing System
Generic name
Stimulator, bone growth, non-invasive
Applicant
Bioventus, LLC
Date received
2019-06-25
Decision date
2019-12-20
Days to decision
178 days
Decision code
APPR
Product code
LOF
Advisory committee
Orthopedic
Expedited review
No
Location
Durham, NC
Statement
Approval for modified indications for use to include adjunctive use in patients with internal or external fracture fixation hardware present, patients undergoing treatment for infection at the fracture site, and patients believed to have diminished bone quality.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
StimTrial Neuromodulation System (K243782)Bioventus, LLC2025-07-16
TalisMann Neuromodulation System (K243678)Bioventus, LLC2025-07-03
Allograft Delivery Device (OFAC-C) (K233368)Bioventus, LLC2024-06-25
SIGNAFUSE Bioactive Strip (SBS); SIGNAFUSE Putty (K233490)Bioventus, LLC2023-12-05
MCS Bone Graft (K162860)Bioventus, LLC2017-02-13